Exploring and bypassing resistance to targeted therapies in colorectal cancer Article Swipe
S Mckenna Favier
,
Kamel Chettab
,
Oliver Piercey
,
Ting Wu
,
Lars Petter Jordheim
,
Charles Dumontet
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.biopha.2025.118741
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.biopha.2025.118741
Colorectal cancer (CRC) remains a leading cause of cancer-related deaths globally, though targeted therapies have transformed treatment and brought renewed hope. However, resistance to these therapies is a persistent challenge, driven by genetic mutations, epigenetic changes, tumor microenvironment (TME) adaptations, and disruptions in key signaling pathways. These mechanisms allow tumor cells to evade treatment, causing disease progression and limiting long-term success. This review highlights recent breakthroughs and innovative strategies aimed at overcoming resistance in CRC. A deeper understanding of tumor heterogeneity, exosome-mediated communication, and the evolving TME is central to this effort. Promising approaches include biomarker-guided combination therapies and the use of epigenetic modulators to disrupt resistance mechanisms and restore treatment efficacy. Emerging studies also reveal the vulnerabilities of cancer persister cells. Targeting these cells, along with addressing cell cycle dysregulation and DNA damage repair (DDR) pathways, offers new opportunities for durable responses. This review serves as a roadmap for tackling resistance in CRC, with the ultimate goal of improving patient outcomes.
Related Topics
Concepts
No concepts available.
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.biopha.2025.118741
- OA Status
- gold
- References
- 203
- OpenAlex ID
- https://openalex.org/W4416202785
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4416202785Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.biopha.2025.118741Digital Object Identifier
- Title
-
Exploring and bypassing resistance to targeted therapies in colorectal cancerWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-11-13Full publication date if available
- Authors
-
S Mckenna Favier, Kamel Chettab, Oliver Piercey, Ting Wu, Lars Petter Jordheim, Charles DumontetList of authors in order
- Landing page
-
https://doi.org/10.1016/j.biopha.2025.118741Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/j.biopha.2025.118741Direct OA link when available
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
203Number of works referenced by this work
Full payload
| id | https://openalex.org/W4416202785 |
|---|---|
| doi | https://doi.org/10.1016/j.biopha.2025.118741 |
| ids.doi | https://doi.org/10.1016/j.biopha.2025.118741 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/41223763 |
| ids.openalex | https://openalex.org/W4416202785 |
| fwci | |
| type | article |
| title | Exploring and bypassing resistance to targeted therapies in colorectal cancer |
| biblio.issue | |
| biblio.volume | 193 |
| biblio.last_page | 118741 |
| biblio.first_page | 118741 |
| is_xpac | False |
| apc_list.value | 2660 |
| apc_list.currency | USD |
| apc_list.value_usd | 2660 |
| apc_paid.value | 2660 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2660 |
| language | en |
| locations[0].id | doi:10.1016/j.biopha.2025.118741 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S15111687 |
| locations[0].source.issn | 0753-3322, 1950-6007 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 0753-3322 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Biomedicine & Pharmacotherapy |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_lineage_names | Elsevier BV |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Biomedicine & Pharmacotherapy |
| locations[0].landing_page_url | https://doi.org/10.1016/j.biopha.2025.118741 |
| locations[1].id | pmid:41223763 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/41223763 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5049646722 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | S Mckenna Favier |
| authorships[0].countries | FR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I100532134, https://openalex.org/I154526488, https://openalex.org/I4210105738, https://openalex.org/I4210125048 |
| authorships[0].affiliations[0].raw_affiliation_string | Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon 69008, France. |
| authorships[0].institutions[0].id | https://openalex.org/I4210105738 |
| authorships[0].institutions[0].ror | https://ror.org/01cmnjq37 |
| authorships[0].institutions[0].type | nonprofit |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210105738 |
| authorships[0].institutions[0].country_code | FR |
| authorships[0].institutions[0].display_name | Centre Léon Bérard |
| authorships[0].institutions[1].id | https://openalex.org/I4210125048 |
| authorships[0].institutions[1].ror | https://ror.org/02mgw3155 |
| authorships[0].institutions[1].type | facility |
| authorships[0].institutions[1].lineage | https://openalex.org/I100532134, https://openalex.org/I1294671590, https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I203339264, https://openalex.org/I4210096427, https://openalex.org/I4210105738, https://openalex.org/I4210125048 |
| authorships[0].institutions[1].country_code | FR |
| authorships[0].institutions[1].display_name | Centre de Recherche en Cancérologie de Lyon |
| authorships[0].institutions[2].id | https://openalex.org/I154526488 |
| authorships[0].institutions[2].ror | https://ror.org/02vjkv261 |
| authorships[0].institutions[2].type | government |
| authorships[0].institutions[2].lineage | https://openalex.org/I154526488 |
| authorships[0].institutions[2].country_code | FR |
| authorships[0].institutions[2].display_name | Inserm |
| authorships[0].institutions[3].id | https://openalex.org/I100532134 |
| authorships[0].institutions[3].ror | https://ror.org/029brtt94 |
| authorships[0].institutions[3].type | education |
| authorships[0].institutions[3].lineage | https://openalex.org/I100532134, https://openalex.org/I203339264 |
| authorships[0].institutions[3].country_code | FR |
| authorships[0].institutions[3].display_name | Université Claude Bernard Lyon 1 |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Solène Favier |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon 69008, France. |
| authorships[1].author.id | https://openalex.org/A5049177336 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-5311-3792 |
| authorships[1].author.display_name | Kamel Chettab |
| authorships[1].countries | FR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I100532134, https://openalex.org/I4210100596, https://openalex.org/I4210105738, https://openalex.org/I4210125048 |
| authorships[1].affiliations[0].raw_affiliation_string | Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon 69008, France; Hospices Civils de Lyon, Lyon, France. |
| authorships[1].institutions[0].id | https://openalex.org/I4210105738 |
| authorships[1].institutions[0].ror | https://ror.org/01cmnjq37 |
| authorships[1].institutions[0].type | nonprofit |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210105738 |
| authorships[1].institutions[0].country_code | FR |
| authorships[1].institutions[0].display_name | Centre Léon Bérard |
| authorships[1].institutions[1].id | https://openalex.org/I4210125048 |
| authorships[1].institutions[1].ror | https://ror.org/02mgw3155 |
| authorships[1].institutions[1].type | facility |
| authorships[1].institutions[1].lineage | https://openalex.org/I100532134, https://openalex.org/I1294671590, https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I203339264, https://openalex.org/I4210096427, https://openalex.org/I4210105738, https://openalex.org/I4210125048 |
| authorships[1].institutions[1].country_code | FR |
| authorships[1].institutions[1].display_name | Centre de Recherche en Cancérologie de Lyon |
| authorships[1].institutions[2].id | https://openalex.org/I4210100596 |
| authorships[1].institutions[2].ror | https://ror.org/01502ca60 |
| authorships[1].institutions[2].type | healthcare |
| authorships[1].institutions[2].lineage | https://openalex.org/I4210100596 |
| authorships[1].institutions[2].country_code | FR |
| authorships[1].institutions[2].display_name | Hospices Civils de Lyon |
| authorships[1].institutions[3].id | https://openalex.org/I100532134 |
| authorships[1].institutions[3].ror | https://ror.org/029brtt94 |
| authorships[1].institutions[3].type | education |
| authorships[1].institutions[3].lineage | https://openalex.org/I100532134, https://openalex.org/I203339264 |
| authorships[1].institutions[3].country_code | FR |
| authorships[1].institutions[3].display_name | Université Claude Bernard Lyon 1 |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Kamel Chettab |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon 69008, France; Hospices Civils de Lyon, Lyon, France. |
| authorships[2].author.id | https://openalex.org/A5083890492 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-2220-2570 |
| authorships[2].author.display_name | Oliver Piercey |
| authorships[2].countries | AU |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I165779595, https://openalex.org/I2800555584 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia; Peter MacCallum Cancer Centre, Department of Medical Oncology, Melbourne, Victoria, Australia. |
| authorships[2].institutions[0].id | https://openalex.org/I2800555584 |
| authorships[2].institutions[0].ror | https://ror.org/02a8bt934 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I2800555584 |
| authorships[2].institutions[0].country_code | AU |
| authorships[2].institutions[0].display_name | Peter MacCallum Cancer Centre |
| authorships[2].institutions[1].id | https://openalex.org/I165779595 |
| authorships[2].institutions[1].ror | https://ror.org/01ej9dk98 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I165779595 |
| authorships[2].institutions[1].country_code | AU |
| authorships[2].institutions[1].display_name | The University of Melbourne |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Oliver Piercey |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia; Peter MacCallum Cancer Centre, Department of Medical Oncology, Melbourne, Victoria, Australia. |
| authorships[3].author.id | https://openalex.org/A5101520253 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-4056-6514 |
| authorships[3].author.display_name | Ting Wu |
| authorships[3].countries | FR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I203339264, https://openalex.org/I4210105738, https://openalex.org/I4210125048 |
| authorships[3].affiliations[0].raw_affiliation_string | LabEx Dev2CAN, Institut Convergence Plascan, Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR5286, Université de Lyon, Université Claude Bernard Lyon, Centre Léon Bérard, Lyon CEDEX 08, France. |
| authorships[3].institutions[0].id | https://openalex.org/I4210105738 |
| authorships[3].institutions[0].ror | https://ror.org/01cmnjq37 |
| authorships[3].institutions[0].type | nonprofit |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210105738 |
| authorships[3].institutions[0].country_code | FR |
| authorships[3].institutions[0].display_name | Centre Léon Bérard |
| authorships[3].institutions[1].id | https://openalex.org/I4210125048 |
| authorships[3].institutions[1].ror | https://ror.org/02mgw3155 |
| authorships[3].institutions[1].type | facility |
| authorships[3].institutions[1].lineage | https://openalex.org/I100532134, https://openalex.org/I1294671590, https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I203339264, https://openalex.org/I4210096427, https://openalex.org/I4210105738, https://openalex.org/I4210125048 |
| authorships[3].institutions[1].country_code | FR |
| authorships[3].institutions[1].display_name | Centre de Recherche en Cancérologie de Lyon |
| authorships[3].institutions[2].id | https://openalex.org/I203339264 |
| authorships[3].institutions[2].ror | https://ror.org/01rk35k63 |
| authorships[3].institutions[2].type | education |
| authorships[3].institutions[2].lineage | https://openalex.org/I203339264 |
| authorships[3].institutions[2].country_code | FR |
| authorships[3].institutions[2].display_name | Université de Lyon |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | Ting Wu |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | LabEx Dev2CAN, Institut Convergence Plascan, Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR5286, Université de Lyon, Université Claude Bernard Lyon, Centre Léon Bérard, Lyon CEDEX 08, France. |
| authorships[4].author.id | https://openalex.org/A5070262210 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-3948-7090 |
| authorships[4].author.display_name | Lars Petter Jordheim |
| authorships[4].countries | FR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I100532134, https://openalex.org/I154526488, https://openalex.org/I4210105738, https://openalex.org/I4210125048 |
| authorships[4].affiliations[0].raw_affiliation_string | Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon 69008, France. |
| authorships[4].institutions[0].id | https://openalex.org/I4210105738 |
| authorships[4].institutions[0].ror | https://ror.org/01cmnjq37 |
| authorships[4].institutions[0].type | nonprofit |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210105738 |
| authorships[4].institutions[0].country_code | FR |
| authorships[4].institutions[0].display_name | Centre Léon Bérard |
| authorships[4].institutions[1].id | https://openalex.org/I4210125048 |
| authorships[4].institutions[1].ror | https://ror.org/02mgw3155 |
| authorships[4].institutions[1].type | facility |
| authorships[4].institutions[1].lineage | https://openalex.org/I100532134, https://openalex.org/I1294671590, https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I203339264, https://openalex.org/I4210096427, https://openalex.org/I4210105738, https://openalex.org/I4210125048 |
| authorships[4].institutions[1].country_code | FR |
| authorships[4].institutions[1].display_name | Centre de Recherche en Cancérologie de Lyon |
| authorships[4].institutions[2].id | https://openalex.org/I154526488 |
| authorships[4].institutions[2].ror | https://ror.org/02vjkv261 |
| authorships[4].institutions[2].type | government |
| authorships[4].institutions[2].lineage | https://openalex.org/I154526488 |
| authorships[4].institutions[2].country_code | FR |
| authorships[4].institutions[2].display_name | Inserm |
| authorships[4].institutions[3].id | https://openalex.org/I100532134 |
| authorships[4].institutions[3].ror | https://ror.org/029brtt94 |
| authorships[4].institutions[3].type | education |
| authorships[4].institutions[3].lineage | https://openalex.org/I100532134, https://openalex.org/I203339264 |
| authorships[4].institutions[3].country_code | FR |
| authorships[4].institutions[3].display_name | Université Claude Bernard Lyon 1 |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Lars Petter Jordheim |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon 69008, France. |
| authorships[5].author.id | https://openalex.org/A5006793451 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-1875-134X |
| authorships[5].author.display_name | Charles Dumontet |
| authorships[5].countries | FR |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I203339264, https://openalex.org/I4210100596, https://openalex.org/I4210105738, https://openalex.org/I4210125048 |
| authorships[5].affiliations[0].raw_affiliation_string | LabEx Dev2CAN, Institut Convergence Plascan, Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR5286, Université de Lyon, Université Claude Bernard Lyon, Centre Léon Bérard, Lyon CEDEX 08, France; Hospices Civils de Lyon, Lyon, France. |
| authorships[5].institutions[0].id | https://openalex.org/I4210105738 |
| authorships[5].institutions[0].ror | https://ror.org/01cmnjq37 |
| authorships[5].institutions[0].type | nonprofit |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210105738 |
| authorships[5].institutions[0].country_code | FR |
| authorships[5].institutions[0].display_name | Centre Léon Bérard |
| authorships[5].institutions[1].id | https://openalex.org/I4210125048 |
| authorships[5].institutions[1].ror | https://ror.org/02mgw3155 |
| authorships[5].institutions[1].type | facility |
| authorships[5].institutions[1].lineage | https://openalex.org/I100532134, https://openalex.org/I1294671590, https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I203339264, https://openalex.org/I4210096427, https://openalex.org/I4210105738, https://openalex.org/I4210125048 |
| authorships[5].institutions[1].country_code | FR |
| authorships[5].institutions[1].display_name | Centre de Recherche en Cancérologie de Lyon |
| authorships[5].institutions[2].id | https://openalex.org/I4210100596 |
| authorships[5].institutions[2].ror | https://ror.org/01502ca60 |
| authorships[5].institutions[2].type | healthcare |
| authorships[5].institutions[2].lineage | https://openalex.org/I4210100596 |
| authorships[5].institutions[2].country_code | FR |
| authorships[5].institutions[2].display_name | Hospices Civils de Lyon |
| authorships[5].institutions[3].id | https://openalex.org/I203339264 |
| authorships[5].institutions[3].ror | https://ror.org/01rk35k63 |
| authorships[5].institutions[3].type | education |
| authorships[5].institutions[3].lineage | https://openalex.org/I203339264 |
| authorships[5].institutions[3].country_code | FR |
| authorships[5].institutions[3].display_name | Université de Lyon |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Charles Dumontet |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | LabEx Dev2CAN, Institut Convergence Plascan, Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR5286, Université de Lyon, Université Claude Bernard Lyon, Centre Léon Bérard, Lyon CEDEX 08, France; Hospices Civils de Lyon, Lyon, France. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/j.biopha.2025.118741 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-11-13T00:00:00 |
| display_name | Exploring and bypassing resistance to targeted therapies in colorectal cancer |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-12-01T00:03:43.161839 |
| primary_topic | |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1016/j.biopha.2025.118741 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S15111687 |
| best_oa_location.source.issn | 0753-3322, 1950-6007 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 0753-3322 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Biomedicine & Pharmacotherapy |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_lineage_names | Elsevier BV |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Biomedicine & Pharmacotherapy |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.biopha.2025.118741 |
| primary_location.id | doi:10.1016/j.biopha.2025.118741 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S15111687 |
| primary_location.source.issn | 0753-3322, 1950-6007 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 0753-3322 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Biomedicine & Pharmacotherapy |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_lineage_names | Elsevier BV |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Biomedicine & Pharmacotherapy |
| primary_location.landing_page_url | https://doi.org/10.1016/j.biopha.2025.118741 |
| publication_date | 2025-11-13 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W3128646645, https://openalex.org/W2093415243, https://openalex.org/W2972102107, https://openalex.org/W3130224122, https://openalex.org/W3011481749, https://openalex.org/W4410634396, https://openalex.org/W4367670315, https://openalex.org/W4401322169, https://openalex.org/W4321602088, https://openalex.org/W2091774189, https://openalex.org/W4366236521, https://openalex.org/W2115735904, https://openalex.org/W2111237964, https://openalex.org/W2800353792, https://openalex.org/W3165227239, https://openalex.org/W4312094576, https://openalex.org/W2065849320, https://openalex.org/W2790124402, https://openalex.org/W2431492348, https://openalex.org/W2588450527, https://openalex.org/W4385555989, https://openalex.org/W2491418081, https://openalex.org/W2168631000, https://openalex.org/W2033278321, https://openalex.org/W3115160710, https://openalex.org/W3111047021, https://openalex.org/W2947574880, https://openalex.org/W2811225034, https://openalex.org/W2808878318, https://openalex.org/W3095894630, https://openalex.org/W2606001457, https://openalex.org/W4387230930, https://openalex.org/W3137840943, https://openalex.org/W2891758593, https://openalex.org/W2946768587, https://openalex.org/W2921383089, https://openalex.org/W2985970369, https://openalex.org/W2994306405, https://openalex.org/W1944995278, https://openalex.org/W2151415279, https://openalex.org/W2611453969, https://openalex.org/W4396899699, https://openalex.org/W4413950846, https://openalex.org/W4403382131, https://openalex.org/W2035252444, https://openalex.org/W3119379269, https://openalex.org/W3199222309, https://openalex.org/W4289730886, https://openalex.org/W2163206184, https://openalex.org/W2062265555, https://openalex.org/W4383737426, https://openalex.org/W4295681609, https://openalex.org/W1983074899, https://openalex.org/W4407230162, https://openalex.org/W4298132797, https://openalex.org/W3202055940, https://openalex.org/W4385490830, https://openalex.org/W2767862821, https://openalex.org/W2510987247, https://openalex.org/W3131032505, https://openalex.org/W3128874927, https://openalex.org/W4382134903, https://openalex.org/W3016730227, https://openalex.org/W4319983267, https://openalex.org/W4386222660, https://openalex.org/W4396896827, https://openalex.org/W2550769275, https://openalex.org/W3119081011, https://openalex.org/W2784768734, https://openalex.org/W2891626316, https://openalex.org/W2159179344, https://openalex.org/W3024670790, https://openalex.org/W4368377274, https://openalex.org/W4399328304, https://openalex.org/W4399737728, https://openalex.org/W3019294197, https://openalex.org/W3052790525, https://openalex.org/W2977895282, https://openalex.org/W4406820204, https://openalex.org/W4387473002, https://openalex.org/W2786945112, https://openalex.org/W4400594726, https://openalex.org/W2920863623, https://openalex.org/W2462620900, https://openalex.org/W2901973709, https://openalex.org/W4404923724, https://openalex.org/W2784868445, https://openalex.org/W4387902879, https://openalex.org/W3177224496, https://openalex.org/W3186275360, https://openalex.org/W2995367800, https://openalex.org/W2597946622, https://openalex.org/W4399328087, https://openalex.org/W4309213161, https://openalex.org/W3127181626, https://openalex.org/W4401519600, https://openalex.org/W4289517136, https://openalex.org/W3010991709, https://openalex.org/W3042318380, https://openalex.org/W2889319456, https://openalex.org/W2127686099, https://openalex.org/W2066616821, https://openalex.org/W3171648992, https://openalex.org/W3035069459, https://openalex.org/W2757812515, https://openalex.org/W1997944395, https://openalex.org/W4407144170, https://openalex.org/W4308423852, https://openalex.org/W4388734937, https://openalex.org/W4285385407, https://openalex.org/W2581841075, https://openalex.org/W4311500919, https://openalex.org/W3200898477, https://openalex.org/W2769426045, https://openalex.org/W4405237978, https://openalex.org/W4380870155, https://openalex.org/W2624499646, https://openalex.org/W4393177010, https://openalex.org/W4307343657, https://openalex.org/W4285600039, https://openalex.org/W4383557607, https://openalex.org/W2116731538, https://openalex.org/W4386546077, https://openalex.org/W2808864948, https://openalex.org/W4303621977, https://openalex.org/W2600631691, https://openalex.org/W2903466791, https://openalex.org/W4312174640, https://openalex.org/W2147458973, https://openalex.org/W3120367735, https://openalex.org/W4404208635, https://openalex.org/W4323924126, https://openalex.org/W3189724491, https://openalex.org/W2148323109, https://openalex.org/W2106391833, https://openalex.org/W4386133984, https://openalex.org/W3001977872, https://openalex.org/W2861285088, https://openalex.org/W2778942513, https://openalex.org/W2960931117, https://openalex.org/W2101399736, https://openalex.org/W2031134972, https://openalex.org/W2111291883, https://openalex.org/W4284707191, https://openalex.org/W4283731799, https://openalex.org/W4296467227, https://openalex.org/W3120564033, https://openalex.org/W4402128677, https://openalex.org/W2767055857, https://openalex.org/W3120587938, https://openalex.org/W2156144699, https://openalex.org/W2553053943, https://openalex.org/W4385576716, https://openalex.org/W4382777594, https://openalex.org/W4388742529, https://openalex.org/W4321485320, https://openalex.org/W2050996284, https://openalex.org/W4282965989, https://openalex.org/W2811407868, https://openalex.org/W1976150924, https://openalex.org/W2986572941, https://openalex.org/W3109716884, https://openalex.org/W2901573161, https://openalex.org/W2727828415, https://openalex.org/W2971457179, https://openalex.org/W4308499091, https://openalex.org/W4366085904, https://openalex.org/W4280554463, https://openalex.org/W3210508637, https://openalex.org/W4310463888, https://openalex.org/W2755975022, https://openalex.org/W4367365845, https://openalex.org/W4392595916, https://openalex.org/W2955589498, https://openalex.org/W4316507345, https://openalex.org/W4280624033, https://openalex.org/W4378675433, https://openalex.org/W4387017277, https://openalex.org/W4388125734, https://openalex.org/W2985795188, https://openalex.org/W2560375214, https://openalex.org/W4403163174, https://openalex.org/W4399840906, https://openalex.org/W2957125530, https://openalex.org/W4412904862, https://openalex.org/W4408149507, https://openalex.org/W4220865192, https://openalex.org/W2960942904, https://openalex.org/W3214055905, https://openalex.org/W2121906867, https://openalex.org/W2614443510, https://openalex.org/W2149441684, https://openalex.org/W4396933741, https://openalex.org/W4408758974, https://openalex.org/W4224238459, https://openalex.org/W4292117133, https://openalex.org/W4385459199, https://openalex.org/W4413028932, https://openalex.org/W4395033074, https://openalex.org/W4313346475, https://openalex.org/W4410939981, https://openalex.org/W4281738617, https://openalex.org/W4401497204 |
| referenced_works_count | 203 |
| abstract_inverted_index.A | 75 |
| abstract_inverted_index.a | 4, 27, 147 |
| abstract_inverted_index.as | 146 |
| abstract_inverted_index.at | 70 |
| abstract_inverted_index.by | 31 |
| abstract_inverted_index.in | 42, 73, 152 |
| abstract_inverted_index.is | 26, 87 |
| abstract_inverted_index.of | 7, 78, 101, 118, 158 |
| abstract_inverted_index.to | 23, 51, 89, 104 |
| abstract_inverted_index.DNA | 132 |
| abstract_inverted_index.TME | 86 |
| abstract_inverted_index.and | 17, 40, 57, 66, 83, 98, 108, 131 |
| abstract_inverted_index.for | 140, 149 |
| abstract_inverted_index.key | 43 |
| abstract_inverted_index.new | 138 |
| abstract_inverted_index.the | 84, 99, 116, 155 |
| abstract_inverted_index.use | 100 |
| abstract_inverted_index.CRC, | 153 |
| abstract_inverted_index.CRC. | 74 |
| abstract_inverted_index.This | 61, 143 |
| abstract_inverted_index.also | 114 |
| abstract_inverted_index.cell | 128 |
| abstract_inverted_index.goal | 157 |
| abstract_inverted_index.have | 14 |
| abstract_inverted_index.this | 90 |
| abstract_inverted_index.with | 126, 154 |
| abstract_inverted_index.(CRC) | 2 |
| abstract_inverted_index.(DDR) | 135 |
| abstract_inverted_index.(TME) | 38 |
| abstract_inverted_index.These | 46 |
| abstract_inverted_index.aimed | 69 |
| abstract_inverted_index.allow | 48 |
| abstract_inverted_index.along | 125 |
| abstract_inverted_index.cause | 6 |
| abstract_inverted_index.cells | 50 |
| abstract_inverted_index.cycle | 129 |
| abstract_inverted_index.evade | 52 |
| abstract_inverted_index.hope. | 20 |
| abstract_inverted_index.these | 24, 123 |
| abstract_inverted_index.tumor | 36, 49, 79 |
| abstract_inverted_index.cancer | 1, 119 |
| abstract_inverted_index.cells, | 124 |
| abstract_inverted_index.cells. | 121 |
| abstract_inverted_index.damage | 133 |
| abstract_inverted_index.deaths | 9 |
| abstract_inverted_index.deeper | 76 |
| abstract_inverted_index.driven | 30 |
| abstract_inverted_index.offers | 137 |
| abstract_inverted_index.recent | 64 |
| abstract_inverted_index.repair | 134 |
| abstract_inverted_index.reveal | 115 |
| abstract_inverted_index.review | 62, 144 |
| abstract_inverted_index.serves | 145 |
| abstract_inverted_index.though | 11 |
| abstract_inverted_index.brought | 18 |
| abstract_inverted_index.causing | 54 |
| abstract_inverted_index.central | 88 |
| abstract_inverted_index.disease | 55 |
| abstract_inverted_index.disrupt | 105 |
| abstract_inverted_index.durable | 141 |
| abstract_inverted_index.effort. | 91 |
| abstract_inverted_index.genetic | 32 |
| abstract_inverted_index.include | 94 |
| abstract_inverted_index.leading | 5 |
| abstract_inverted_index.patient | 160 |
| abstract_inverted_index.remains | 3 |
| abstract_inverted_index.renewed | 19 |
| abstract_inverted_index.restore | 109 |
| abstract_inverted_index.roadmap | 148 |
| abstract_inverted_index.studies | 113 |
| abstract_inverted_index.Emerging | 112 |
| abstract_inverted_index.However, | 21 |
| abstract_inverted_index.changes, | 35 |
| abstract_inverted_index.evolving | 85 |
| abstract_inverted_index.limiting | 58 |
| abstract_inverted_index.success. | 60 |
| abstract_inverted_index.tackling | 150 |
| abstract_inverted_index.targeted | 12 |
| abstract_inverted_index.ultimate | 156 |
| abstract_inverted_index.Promising | 92 |
| abstract_inverted_index.Targeting | 122 |
| abstract_inverted_index.efficacy. | 111 |
| abstract_inverted_index.globally, | 10 |
| abstract_inverted_index.improving | 159 |
| abstract_inverted_index.long-term | 59 |
| abstract_inverted_index.outcomes. | 161 |
| abstract_inverted_index.pathways, | 136 |
| abstract_inverted_index.pathways. | 45 |
| abstract_inverted_index.persister | 120 |
| abstract_inverted_index.signaling | 44 |
| abstract_inverted_index.therapies | 13, 25, 97 |
| abstract_inverted_index.treatment | 16, 110 |
| abstract_inverted_index.Colorectal | 0 |
| abstract_inverted_index.addressing | 127 |
| abstract_inverted_index.approaches | 93 |
| abstract_inverted_index.challenge, | 29 |
| abstract_inverted_index.epigenetic | 34, 102 |
| abstract_inverted_index.highlights | 63 |
| abstract_inverted_index.innovative | 67 |
| abstract_inverted_index.mechanisms | 47, 107 |
| abstract_inverted_index.modulators | 103 |
| abstract_inverted_index.mutations, | 33 |
| abstract_inverted_index.overcoming | 71 |
| abstract_inverted_index.persistent | 28 |
| abstract_inverted_index.resistance | 22, 72, 106, 151 |
| abstract_inverted_index.responses. | 142 |
| abstract_inverted_index.strategies | 68 |
| abstract_inverted_index.treatment, | 53 |
| abstract_inverted_index.combination | 96 |
| abstract_inverted_index.disruptions | 41 |
| abstract_inverted_index.progression | 56 |
| abstract_inverted_index.transformed | 15 |
| abstract_inverted_index.adaptations, | 39 |
| abstract_inverted_index.breakthroughs | 65 |
| abstract_inverted_index.dysregulation | 130 |
| abstract_inverted_index.opportunities | 139 |
| abstract_inverted_index.understanding | 77 |
| abstract_inverted_index.cancer-related | 8 |
| abstract_inverted_index.communication, | 82 |
| abstract_inverted_index.heterogeneity, | 80 |
| abstract_inverted_index.vulnerabilities | 117 |
| abstract_inverted_index.biomarker-guided | 95 |
| abstract_inverted_index.exosome-mediated | 81 |
| abstract_inverted_index.microenvironment | 37 |
| cited_by_percentile_year | |
| countries_distinct_count | 2 |
| institutions_distinct_count | 6 |
| citation_normalized_percentile |